Omeros reported $158.7M in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acelrx Pharmaceuticals ACRX:US USD 31M 5M
Adma Biologics ADMA:US USD 478M 89M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Cytokinetics CYTK:US USD 4.56B 1.2B
Dynavax Technologies DVAX:US USD 1.32B 270M
Gilead Sciences GILD:US USD 77.36B 170M
Heron Therapeutics HRTX:US USD 501M 215M
Insmed INSM:US USD 2.62B 258M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Knight Therapeutics Inc GUD:CN CAD 607.68M 5.36M
Macrogenics MGNX:US USD 213M 32M
Mirati Therapeutics MRTX:US USD 3.88B 156M
Omeros OMER:US USD 198M 25M
Pacira Pharmaceuticals PCRX:US USD 2.44B 212M
Pfizer PFE:US USD 245.6B 48.58B
Regulus Therapeutics RGLS:US USD 25M 5M
Rockwell Medical RMTI:US USD 15M 3M
Sangamo Biosciences SGMO:US USD 767M 160M
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
United Therapeutics UTHR:US USD 9.53B 1.14B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
Vital Therapies VTL:US USD 97M 21M
Xoma XOMA:US USD 205M 50M